{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:53:22Z","timestamp":1793933602679,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["Dnr: 20180709"],"award-info":[{"award-number":["Dnr: 20180709"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["Dnr: FR-2019\/0007"],"award-info":[{"award-number":["Dnr: FR-2019\/0007"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Diabetes Foundation and Excellence of Diabetes Research in Sweden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polyunsaturated fatty acids (PUFA) have been shown to reduce liver fat compared to saturated fat, but effects of a novel \u201canti-lipogenic\u201d diet replacing carbohydrates with PUFA (LCPUFA) or a low-fat healthy Nordic diet (HND) rich in whole-grains are unknown. The objective of this study was to investigate the effects of these diets, as compared with usual care (UC), on liver fat (primary outcome) and related glycemic and lipid disorders after 12 months of intervention, in individuals with prediabetes or type 2 diabetes (T2D). A three-arm parallel ad libitum randomized trial was completed in December 2022 (NCT04527965). Outcome assessors and care providers were blinded to participants\u2019 diets. Men and women (n=150) with prediabetes or T2D (55%) were randomized in a 1:1:1 allocation ratio, stratified by sex and T2D status, and were assessed at the Uppsala Academic hospital. General linear models were employed to estimate intention-to-treat effects. Liver fat was reduced after the LCPUFA diet (n=54) and the HND (n=51) when compared to UC (n=43); -1.46% (95% CI: -2.42, -0.51)) and -1.76 % (95% CI: -2.96, -0.57), respectively. No difference in liver fat between LCPUFA and HND was observed. Body weight and HbA1c decreased more in the HND versus the other diets, whereas no differences were observed between LCPUFA and UC. LDL-cholesterol was reduced to a similar extent during the HND and LCPUFA diet, compared to UC, whereas only HND reduced triglycerides, inflammation and liver enzymes. In total, n=4 serious adverse events occurred, distributed among groups. An ad libitum mainly plant-based LCPUFA diet and HND similarly reduced liver fat and LDL-cholesterol, compared with UC. Even without intentional energy restriction, the HND further improved body weight, glycemic control, liver biochemistry, triglycerides, and inflammation, suggesting a HND as a clinically feasible diet for the management of T2D and metabolic dysfunction-associated steatotic liver disease (MASLD).<\/jats:p>","DOI":"10.1038\/s41467-025-65613-2","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:33:39Z","timestamp":1765611219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)"],"prefix":"10.1038","volume":"16","author":[{"given":"Michael","family":"Frid\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rosqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-9047","authenticated-orcid":false,"given":"Lars","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vessby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Martinell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ola","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hulthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-3497","authenticated-orcid":false,"given":"Lars","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Erik","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-8454","authenticated-orcid":false,"given":"Johan","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-7608","authenticated-orcid":false,"given":"Rikard","family":"Landberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-2503","authenticated-orcid":false,"given":"Marju","family":"Orho-Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-4586","authenticated-orcid":false,"given":"Ulf","family":"Ris\u00e9rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"65613_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/dc17-1902","volume":"41","author":"A Mantovani","year":"2018","unstructured":"Mantovani, A., Byrne, C. D., Bonora, E. & Targher, G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care 41, 372\u2013382 (2018).","journal-title":"Diabetes Care"},{"key":"65613_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","volume":"165","author":"DQ Huang","year":"2023","unstructured":"Huang, D. Q. et al. Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study. Gastroenterology 165, 463\u2013472 (2023).","journal-title":"Gastroenterology"},{"key":"65613_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher, G., Corey, K. E., Byrne, C. D. & Roden, M. The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol. 18, 599\u2013612 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"65613_CR4","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3945\/ajcn.111.030114","volume":"95","author":"H Bjermo","year":"2012","unstructured":"Bjermo, H. et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr. 95, 1003\u20131012 (2012).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR5","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db13-1622","volume":"63","author":"F Rosqvist","year":"2014","unstructured":"Rosqvist, F. et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63, 2356\u20132368 (2014).","journal-title":"Diabetes"},{"key":"65613_CR6","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1210\/jc.2019-00160","volume":"104","author":"F Rosqvist","year":"2019","unstructured":"Rosqvist, F. et al. Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial. J. Clin. Endocrinol. Metab. 104, 6207\u20136219 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65613_CR7","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1007\/s00125-019-4956-4","volume":"62","author":"MJ Skytte","year":"2019","unstructured":"Skytte, M. J. et al. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. Diabetologia 62, 2066\u20132078 (2019).","journal-title":"Diabetologia"},{"key":"65613_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","volume":"59","author":"MC Ryan","year":"2013","unstructured":"Ryan, M. C. et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J. Hepatol. 59, 138\u2013143 (2013).","journal-title":"J. Hepatol."},{"key":"65613_CR9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1017\/S0007114512002966","volume":"109","author":"KM Utzschneider","year":"2013","unstructured":"Utzschneider, K. M. et al. Beneficial effect of a weight-stable, low-fat\/low-saturated fat\/low-glycaemic index diet to reduce liver fat in older subjects. Br. J. Nutr. 109, 1096\u20131104 (2013).","journal-title":"Br. J. Nutr."},{"key":"65613_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/dom.12784","volume":"19","author":"S Bawden","year":"2017","unstructured":"Bawden, S. et al. Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: a randomized crossover study. Diabetes, Obes. Metab. 19, 70\u201377 (2017).","journal-title":"Diabetes, Obes. Metab."},{"key":"65613_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/nu15030735","volume":"15","author":"J Basset-Sagarminaga","year":"2023","unstructured":"Basset-Sagarminaga, J. et al. Replacing foods with a high-glycemic index and high in saturated fat by alternatives with a low glycemic index and low saturated fat reduces hepatic fat, even in isocaloric and macronutrient matched conditions. Nutrients 15, 735 (2023).","journal-title":"Nutrients"},{"key":"65613_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ajcn\/nqac025","volume":"116","author":"S Schutte","year":"2022","unstructured":"Schutte, S. et al. Diverging metabolic effects of two energy restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity. Am. J. Clin. Nutr. 116, 132\u2013150 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR13","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1210\/jc.2004-1983","volume":"90","author":"J Westerbacka","year":"2005","unstructured":"Westerbacka, J. et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 90, 2804\u20132809 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65613_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.clnu.2020.07.013","volume":"40","author":"SA Parry","year":"2021","unstructured":"Parry, S. A., Rosqvist, F., Cornfield, T., Barrett, A. & Hodson, L. Oxidation of dietary linoleate occurs to a greater extent than dietary palmitate in vivo in humans. Clin. Nutr. 40, 1108\u20131114 (2021).","journal-title":"Clin. Nutr."},{"key":"65613_CR15","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1017\/S0007114500000969","volume":"83","author":"SD Clarke","year":"2000","unstructured":"Clarke, S. D. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br. J. Nutr. 83, S59\u2013S66 (2000).","journal-title":"Br. J. Nutr."},{"key":"65613_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00125-023-05894-8","volume":"66","author":"A-M Aas","year":"2023","unstructured":"Aas, A.-M. et al. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia 66, 965\u2013985 (2023).","journal-title":"Diabetologia"},{"key":"65613_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2796.2010.02290.x","volume":"269","author":"V Adamsson","year":"2011","unstructured":"Adamsson, V. et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J. Intern. Med. 269, 150\u2013159 (2011).","journal-title":"J. Intern. Med."},{"key":"65613_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/joim.12044","volume":"274","author":"M Uusitupa","year":"2013","unstructured":"Uusitupa, M. et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome\u2013a randomized study SYSDIET. J. Intern. Med. 274, 52\u201366 (2013).","journal-title":"J. Intern. Med."},{"key":"65613_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3945\/ajcn.113.069393","volume":"99","author":"SK Poulsen","year":"2014","unstructured":"Poulsen, S. K. et al. Health effect of the New Nordic Diet in adults with increased waist circumference: a 6-mo randomized controlled trial. Am. J. Clin. Nutr. 99, 35\u201345 (2014).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR20","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00125-022-05760-z","volume":"65","author":"P Massara","year":"2022","unstructured":"Massara, P. et al. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials. Diabetologia 65, 2011\u20132031 (2022).","journal-title":"Diabetologia"},{"key":"65613_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M22-1787","volume":"176","author":"CD Hansen","year":"2023","unstructured":"Hansen, C. D. et al. Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease. Ann. Intern. Med. 176, 10\u201321 (2023).","journal-title":"Ann. Intern. Med."},{"key":"65613_CR22","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2337\/dc18-0071","volume":"41","author":"PK Luukkonen","year":"2018","unstructured":"Luukkonen, P. K. et al. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 41, 1732\u20131739 (2018).","journal-title":"Diabetes Care"},{"key":"65613_CR23","doi-asserted-by":"publisher","unstructured":"Ruuth, M. et al. Overfeeding saturated fat increases LDL (low-density lipoprotein) aggregation susceptibility while overfeeding unsaturated fat decreases proteoglycan-binding of lipoproteins. Arterioscler. Thromb. Vasc. Biol. 41, https:\/\/doi.org\/10.1161\/ATVBAHA.120.315766 (2021).","DOI":"10.1161\/ATVBAHA.120.315766"},{"key":"65613_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3945\/ajcn.115.107045","volume":"102","author":"F Rosqvist","year":"2015","unstructured":"Rosqvist, F. et al. Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study. Am. J. Clin. Nutr. 102, 20\u201330 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/ajcn\/nqy304","volume":"109","author":"F Rosqvist","year":"2019","unstructured":"Rosqvist, F. et al. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers. Am. J. Clin. Nutr. 109, 260\u2013268 (2019).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR26","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley, T. M. et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 143, e984\u2013e1010 (2021).","journal-title":"Circulation"},{"key":"65613_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1017\/S000711451600341X","volume":"116","author":"HVT Ho","year":"2016","unstructured":"Ho, H. V. T. et al. The effect of oat \u03b2-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 116, 1369\u20131382 (2016).","journal-title":"Br. J. Nutr."},{"key":"65613_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","volume":"393","author":"A Reynolds","year":"2019","unstructured":"Reynolds, A. et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393, 434\u2013445 (2019).","journal-title":"Lancet"},{"key":"65613_CR29","doi-asserted-by":"publisher","first-page":"e020167","DOI":"10.1136\/bmjopen-2017-020167","volume":"8","author":"K-T Khaw","year":"2018","unstructured":"Khaw, K.-T. et al. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women. BMJ Open 8, e020167 (2018).","journal-title":"BMJ Open"},{"key":"65613_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","volume":"71","author":"N Tamaki","year":"2022","unstructured":"Tamaki, N. et al. Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut 71, 983\u2013990 (2022).","journal-title":"Gut"},{"key":"65613_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon, T. G., Roelstraete, B., Khalili, H., Hagstr\u00f6m, H. & Ludvigsson, J. F. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 70, 1375\u20131382 (2021).","journal-title":"Gut"},{"key":"65613_CR32","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/hep.31845","volume":"74","author":"TG Simon","year":"2021","unstructured":"Simon, T. G. et al. Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study. Hepatology 74, 2410\u20132423 (2021).","journal-title":"Hepatology"},{"key":"65613_CR33","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38, 2459\u20132472 (2017).","journal-title":"Eur. Heart J."},{"key":"65613_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/EDE.0000000000000564","volume":"28","author":"MA Mansournia","year":"2017","unstructured":"Mansournia, M. A., Higgins, J. P. T., Sterne, J. A. C. & Hern\u00e1n, M. A. Biases in randomized trials. Epidemiology 28, 54\u201359 (2017).","journal-title":"Epidemiology"},{"key":"65613_CR35","doi-asserted-by":"crossref","unstructured":"Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","DOI":"10.1097\/HEP.0000000000000520"},{"key":"65613_CR36","doi-asserted-by":"crossref","unstructured":"Hagstr\u00f6m, H., Vessby, J., Ekstedt, M. & Shang, Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J. Hepatol. 80, E76\u2013E77 (2024).","DOI":"10.1016\/j.jhep.2023.08.026"},{"key":"65613_CR37","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.tjnut.2023.01.005","volume":"153","author":"MF Bajahzer","year":"2023","unstructured":"Bajahzer, M. F. et al. Contrasting carbohydrate quantity and quality and the effects on plasma saturated and monounsaturated fatty acids in healthy adults: a randomized controlled trial. J. Nutr. 153, 683\u2013690 (2023).","journal-title":"J. Nutr."},{"key":"65613_CR38","doi-asserted-by":"publisher","first-page":"936828","DOI":"10.3389\/fnut.2022.936828","volume":"9","author":"MF Bajahzer","year":"2022","unstructured":"Bajahzer, M. F. et al. Effects of sugar-sweetened soda on plasma saturated and monounsaturated fatty acids in individuals with obesity: a randomized study. Front. Nutr. 9, 936828 (2022).","journal-title":"Front. Nutr."},{"key":"65613_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3945\/ajcn.114.092262","volume":"101","author":"JJ Lee","year":"2015","unstructured":"Lee, J. J. et al. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am. J. Clin. Nutr. 101, 34\u201343 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1017\/S0007114500002154","volume":"84","author":"GC Burdge","year":"2000","unstructured":"Burdge, G. C., Wright, P., Jones, A. E. & Wootton, S. A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br. J. Nutr. 84, 781\u2013787 (2000).","journal-title":"Br. J. Nutr."},{"key":"65613_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2015.12.023","volume":"499","author":"AB Ross","year":"2016","unstructured":"Ross, A. B. et al. A high-throughput method for liquid chromatography\u2013tandem mass spectrometry determination of plasma alkylresorcinols, biomarkers of whole grain wheat and rye intake. Anal. Biochem. 499, 1\u20137 (2016).","journal-title":"Anal. Biochem."},{"key":"65613_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12263-019-0651-9","volume":"14","author":"R Landberg","year":"2019","unstructured":"Landberg, R. et al. Biomarkers of cereal food intake. Genes Nutr. 14, 28 (2019).","journal-title":"Genes Nutr."},{"key":"65613_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-00889-5_1","volume":"11045","author":"Z Zhou","year":"2018","unstructured":"Zhou, Z., Siddiquee, M. M. R., Tajbakhsh, N. & Liang, J. UNet++: a nested U-net architecture for medical image segmentation. Deep Learn. Med. Image Anal. Multimodal. Learn. Clin. Decis. Support 11045, 3\u201311 (2018).","journal-title":"Deep Learn. Med. Image Anal. Multimodal. Learn. Clin. Decis. Support"},{"key":"65613_CR44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy, C., Reeder, S. B., Sirlin, C. B. & Loomba, R. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68, 763\u2013772 (2018).","journal-title":"Hepatology"},{"key":"65613_CR45","doi-asserted-by":"crossref","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367 (2011).","DOI":"10.18637\/jss.v045.i03"},{"key":"65613_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/pst.210","volume":"5","author":"U Meier","year":"2006","unstructured":"Meier, U. A note on the power of Fisher\u2019s least significant difference procedure. Pharm. Stat. 5, 253\u2013263 (2006).","journal-title":"Pharm. Stat."},{"key":"65613_CR47","doi-asserted-by":"publisher","first-page":"1220S","DOI":"10.1093\/ajcn\/65.4.1220S","volume":"65","author":"WC Willett","year":"1997","unstructured":"Willett, W. C., Howe, G. R. & Kushi, L. H. Adjustment for total energy intake in epidemiologic studies. Am. J. Clin. Nutr. 65, 1220S\u20131228S (1997).","journal-title":"Am. J. Clin. Nutr."},{"key":"65613_CR48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1214\/20-STS793","volume":"36","author":"PT von Hippel","year":"2021","unstructured":"von Hippel, P. T. & Bartlett, J. W. Maximum likelihood multiple imputation: faster imputations and consistent standard errors without posterior draws. Stat. Sci. 36, 400\u2013420 (2021).","journal-title":"Stat. Sci."},{"key":"65613_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1037\/tra0001421","volume":"15","author":"Y Li","year":"2023","unstructured":"Li, Y., Yoshida, K., Kaufman, J. S. & Mathur, M. B. A brief primer on conducting regression-based causal mediation analysis. Psychol. Trauma Theory, Res. Pract. Policy 15, 930\u2013938 (2023).","journal-title":"Psychol. Trauma Theory, Res. Pract. Policy"},{"key":"65613_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland, S., Pearl, J. & Robins, J. M. Causal diagrams for epidemiologic research. Epidemiology 10, 37\u201348 (1999).","journal-title":"Epidemiology"},{"key":"65613_CR51","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/EDE.0000000000001064","volume":"30","author":"LH Smith","year":"2019","unstructured":"Smith, L. H. & VanderWeele, T. J. Mediational E-values. Epidemiology 30, 835\u2013837 (2019).","journal-title":"Epidemiology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65613-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65613-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65613-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:04:21Z","timestamp":1765811061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65613-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65613"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65613-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.V. reports advisory board for Novo Nordisk, and lecture fees from Gore Medical and Norgine. J.S. reports direct or indirect stock ownership in companies (Anagram kommunikation AB, Sence Research AB, Symptoms Europe AB, MinForskning AB), providing services to companies and authorities in the health sector, including Amgen, AstraZeneca, Bayer, Boehringer, Eli Lilly, Gilead, GSK, G\u00f6teborg University, Itrim, Ipsen, Janssen, Karolinska Institutet, LIF, Link\u00f6ping University, Novo Nordisk, Parexel, Pfizer, Region Stockholm, Region Uppsala, Sanofi, STRAMA, Takeda, TLV, Uppsala University, Vifor Pharma, WeMind. J.K. reports being co-founder, stock owner and part time employee at Antaros Medical AB. No other competing interests are reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11130"}}